key: cord-0855199-t9kwu0i3 authors: Fritz, Matthieu; Rosolen, Béatrice; Krafft, Emilie; Becquart, Pierre; Elguero, Eric; Vratskikh, Oxana; Denolly, Solène; Boson, Bertrand; Vanhomwegen, Jessica; Ar Gouilh, Meriadeg; Kodjo, Angeli; Chirouze, Catherine; Rosolen, Serge; Legros, Vincent; Leroy, Eric M. title: High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households date: 2020-09-22 journal: bioRxiv DOI: 10.1101/2020.09.22.307751 sha: b54548a427849d5de5e68f6fb778a1d639458d11 doc_id: 855199 cord_uid: t9kwu0i3 In a survey of household cats and dogs of laboratory-confirmed COVID-19 patients, we found a high seroprevalence of SARS-CoV-2 antibodies, ranging from 21% to 53%, depending on the positivity criteria chosen. Seropositivity was significantly greater among pets from COVID-19+ households compared to those with owners of unknown status. Our results highlight the potential role of pets in the spread of the epidemic. Canine CoVs) 1 , and thus may be susceptible to SARS-CoV-2, which also belongs to the 48 Betacoronavirus group. In Europe, the prevalence of canine coronavirus infection is low 2 . Feline 49 coronavirus prevalence is higher 3-5 , with typical seroprevalence ranging from 50% in healthy Swiss 50 cats to 37% in Japan. Additionally, epidemiological, biological, and virological characteristics of 51 coronaviruses, mainly based on Spike-protein plasticity, suggest species barriers to infection may be 52 easily crossed. Thus, pet contamination by sick owners is not only likely but perhaps expected, given 53 the numerous opportunities for spillover [6] [7] [8] . The observation of several cases of mild infections in 54 dogs and cats of infected owners, and serological surveys of pet populations reporting infection rates 55 ranging from 0% to 15,8% 9-12 , highlight this risk. Yet, despite these observations, studies continue to 56 suggest that the risk of contamination of pets by their owners is low and that the role of pets in the 57 spread of the outbreak is trivial or nonexistent. Presently there is no published study accurately assessing the contamination levels in household Though we cannot definitively prove that all the ten positive animals were infected with SARS-CoV-2, 89 the much greater seroprevalence in animals from COVID-19+ households provides strong evidence 90 that pets have been infected with SARS-CoV-2. The highly variable antibody responses to SARS-CoV-2 in human infections 13,14 , calls into question our A recent Swiss study found that anti-N antibody assays substantially underestimate (i.e., by 30% to 97 45%) the proportion of SARS-CoV-2 exposed individuals compared to anti-S antibody assays in 98 population-based seroprevalence studies 15 . Assuming similar dynamics in pets, the actual 99 seropositivity in COVID-19+ households is likely closer to 53% than 21%, indicating that infection risk 100 in the pets of COVID-19 positive owners is much higher than previously described. Given that cats 101 and dogs may become infected, do they contribute to COVID-19 spread due to spillover back into Unknown status households were those with no confirmed SARS-CoV-2 infected person (Black). Control include pre-pandemic population (Grey) and FIPV infected cats (Brown). a: Anti-N antibody 246 levels. b: Anti-S1 antibody levels. c: Anti-S2 antibody levels. SARS-CoV-2 specific antibody levels were Feline and canine coronaviruses: common genetic and pathobiological features Prevalence of canine enteric coronavirus in a cross-sectional survey of dogs 204 presenting at veterinary practices Seroprevalence study of feline 206 coronavirus in owned and feral cats in Sydney Feline coronavirus serotypes 1 and 2: seroprevalence and association 209 with disease in Switzerland Prevalence of feline coronavirus antibodies in Japanese 211 domestic cats during the past decade The proximal origin of 213 SARS-CoV-2 The risk of SARS-CoV-2 transmission to pets 215 and other wild and domestic animals strongly mandates a one-health strategy to control the 216 COVID-19 pandemic. One Health Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS 219 Severe Acute Respiratory Syndrome 221 Coronavirus 2-Specific Antibodies in Pets in Wuhan Serological survey of SARS-CoV-2 for experimental, domestic, companion and 223 wild animals excludes intermediate hosts of 35 different species of animals First detection and genome sequencing of SARS-CoV-2 in an infected cat in 226 Infection of dogs with SARS-CoV-2 A comparison of four serological assays for detecting anti-SARS-CoV-2 229 antibodies in human serum samples from different populations Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody 232 Responses in Coronavirus Disease Patients. Emerging Infectious Disease journal 26 Changes in SARS-CoV-2 Antibody Responses Impact the Estimates of 235 Infections in Population-Based Seroprevalence Studies. medRxiv